黄芪注射液治疗心律失常患者的临床疗效
2016-01-27常良
常 良
黄芪注射液治疗心律失常患者的临床疗效
常 良
【摘要】目的 探讨黄芪注射液治疗心律失常患者的临床疗效。方法 将190例严重心律失常患者按随机数字表法分为观察组和对照组,各95例。对照组患者给予常规抗心律失常、溶栓、降脂、抗凝、抗血小板聚集治疗,观察组患者在对照组治疗基础上加用黄芪注射液治疗。比较两组患者的治疗效果及心肌酶谱。结果 观察组患者总有效率高于对照组,血清乳酸脱氢酶(LDH)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、天冬氨酸转氨酶(AST)均低于对照组(P<0.05)。结论 在常规治疗基础上加用黄芪注射液治疗,可有效缓解心律失常患者的临床症状,改善心功能,提高临床治疗效果。
【关键词】心律失常;黄芪注射液;疗效;心肌酶谱
【中图分类号】R541.7
【文献标志码】A
【文章编号】1673-5846(2015)10-0066-03
【Abstract】Objective To investigate the clinical efficacy of astragalus injection treating arrhythmia patients.
河南省西华县人民医院,河南周口 466600
The Clinical Efficacy of the Treatment of Patients with Arrhythmia Huangqi
Chang Liang
Methods 190 cases of severe arrhythmia patients were randomly divided into observation group and control group, 95 cases.In the control group were treated with conventional anti-arrhythmia,thrombolysis,lipid-lowering,anticoagulant,anti-platelet aggregation therapy was observed in patients astragalus injection therapy in the control group basis.Treatment and myocardial enzymes were compared indicators of the patient.Results Observation group were higher than the total efficiency,serum lactate dehydrogenase(LDH),creatine kinase(CK),creatine kinase(CK-MB), aspartate aminotransferase(AST)were low in the control group(P<0.05).Conclusions Based on conventional therapy plus astragalus treatment can effectively relieve symptoms of patients with arrhythmia,improve heart function, improve clinical outcomes..
【Key words】Arrhythmia;Astragalus injection;Curative effect;Myocardial enzyme spectrum
心律失常是临床心血管内科常见病,严重心律失常患者若得不到及时有效的治疗,可导致心力衰竭、猝死等。目前,临床治疗心律失常以溶栓、降脂、抗凝、抗血小板聚集等西药综合治疗为主[1]。近年来,临床采用中药制剂黄芪注射液治疗心律失常患者取得了较好的治疗效果。本研究采用常规西药联合黄芪注射液治疗心律失常患者,对其临床治疗效果进行探讨,现报道如下。
1 资料与方法
1.1 一般资料 选取2012年10月至2014年10月我院心血管内科住院治疗的190例心律失常患者作为研究对象,其中男112例,女78例,年龄34~72岁,平均(49±6)岁;病程7 d至6年,平均(3.2± 1.0)年。频发室性早搏67例,室上性心动过速18例,频发房性早搏57例,快速心房颤动26例,窦性心动过速14例,窦性心动过缓8例。……
